Quote
|
Profile
|
Overview
|
Calendar
|
Email Alert
|
Request Information
|
My b2i™
Analysts
|
Governance
|
Downloads
|
News
|
Contact Us
AtriCure Appoints Shlomi Nachman to the Board of Directors
Verrica Pharmaceuticals Announces Receipt of Minutes from Type C Meeting with FDA Regarding Clinical Development of YCANTH™ for the Treatment of Common Warts
ROME Therapeutics Appoints Heike Keilhack, Ph.D., as Chief Scientific Officer
Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Revenues
Octapharma Announces Availability of Balfaxar® For Warfarin Reversal in Urgent Surgery & Invasive Procedures
4DMT and Arbor Biotechnologies Establish Partnership to Co-Develop and Co-Commercialize Next-Generation Genetic Medicines for CNS Diseases
On Target Laboratories Names Scott Huennekens as Executive Chairperson of the Board
4DMT and Arbor Biotechnologies Establish Partnership to Co-Develop and Co-Commercialize Next-Generation Genetic Medicines for CNS Diseases
Bluejay Diagnostics Announces Closing of $3.5 Million Public Offering
Processa Pharmaceuticals to Present at the Biotech Showcase 2024
2
3
4
5
6
7
8
9
10
11
12
<<
<
>
>>
Privacy